Nalaganje...
Ponatinib treatment promotes arterial thrombosis and hyperactive platelets
Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.
Shranjeno v:
| izdano v: | Blood Adv |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693004/ https://ncbi.nlm.nih.gov/pubmed/31383636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000034 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|